Cargando…
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
SIMPLE SUMMARY: Mitochondria, often called “the powerhouse of the cell”, generate most of the energy required for all cellular processes. Mitochondria also provide a platform for multiple functions, including building essential macromolecules (nucleotides, proteins, and lipids), cell signaling, deto...
Autores principales: | Wedam, Rohan, Greer, Yoshimi Endo, Wisniewski, David J., Weltz, Sarah, Kundu, Manjari, Voeller, Donna, Lipkowitz, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093243/ https://www.ncbi.nlm.nih.gov/pubmed/37046596 http://dx.doi.org/10.3390/cancers15071936 |
Ejemplares similares
-
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis
por: Greer, Yoshimi Endo, et al.
Publicado: (2022) -
Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2
por: Benaroudj, Nadia, et al.
Publicado: (2011) -
Characterization of TR‐107, a novel chemical activator of the human mitochondrial protease ClpP
por: Fennell, Emily M. J., et al.
Publicado: (2022) -
Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer
por: Fennell, Emily M. J., et al.
Publicado: (2023) -
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
por: Kundu, Manjari, et al.
Publicado: (2022)